First Thoughts Renal Cell Carcinoma (RCC) Meeting 2022

The ever-changing landscape in RCC

29 | 06 | 22

The Royal College of Physicians

11 St Andrews Place, London NW1 4LE

29 | 06 | 22

Dear Partners in RCC,

On behalf of Eisai, I am writing to invite you to the first in-person ‘First Thoughts RCC’ meeting.

This meeting is for oncologists, CNSs and pharmacists from across the UK and will provide the most recent update on the management of RCC. The agenda is highly topical, addressing the reality we all face in clinical practice.

I would like to formally acknowledge the critical support of our Steering Committee members in designing the RCC Agenda, and the panel of experts presenting on the day.

We hope that you will accept this invitation to join us at the ‘First Thoughts RCC’ meeting.

Many thanks.

Professor Tom Powles

Professor Tom Powles

Professor Tom Powles, MBBS, MRCP, MD

Professor of Genitourinary Oncology Director, Barts Cancer Centre, London

CPD accreditation has been applied for.



Kisplyx (lenvatinib) (RCC) Prescribing Information

Steering Committee

Prof Tom Powles

Oncologist, Barts Cancer Centre, London

Dr Jahangeer Malik

Oncologist, Edinburgh Cancer Centre, Edinburgh

Dr Anand Sharma

Oncologist, Mount Vernon Cancer Centre, Northwood

Mr James Armitage

Urologist, Addenbrooke’s Hospital, Cambridge

Lesley Cooper

CNS, Guy’s and St Thomas’, London

Date of preparation: March 2022 | Job Code: UK-KIS-21-00107

By continuing to use this website you are agreeing to our use of cookies.